Stay updated with breaking news from Nasdaq Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benchmark reissued their buy rating on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report issued on Friday, Benzinga reports. The firm currently has a $120.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued reports about the stock. Robert W. Baird cut their price target on shares of Bio-Techne […]
Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 26,662 shares of the biotechnology company’s stock after acquiring an additional 129 shares during the quarter. […]
Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,662 shares of the biotechnology company’s stock after purchasing an additional 129 shares during […]
S&CO Inc. boosted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,350 shares of the biotechnology company’s stock after purchasing an additional 270 shares during the quarter. S&CO Inc.’s holdings in Bio-Techne were […]
Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the period. Barclays PLC’s holdings […]